🇺🇸 FDA
Pipeline program

Copegus

NV19865

Phase 2 small_molecule completed

Quick answer

Copegus for Hepatitis C, Chronic is a Phase 2 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoffmann-La Roche
Indication
Hepatitis C, Chronic
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials